T−TUBES® chosen for Europe''s largest BioPharma facility

Zotefoams plc has been awarded a contract to supply their T-−TUBES® high performance clean room insulation system for Pfizer’s Grange Castle facility in Dublin.

A total of 6.6 km of the inherently pure and chemically resistant T−TUBES® product will be installed in the purification, cell culture and harvest and recovery suites, for heat and energy conservation, personal protection and the elimination of condensation and risk of bacteria growth. This combination of features makes T-TUBES® the clean room insulation of choice at Pfizer’s major European Bio−pharmaceutical plant.

T−TUBES® simple, thermoformed construction reduces installation time, which will assist in the rapid completion and commissioning of the expanded Grange Castle facility that is to host the manufacture of an active pharmaceutical ingredient (API) for Pfizer''s biologic drug program.

The unique KYNAR® PVDF closed cell structure of the foam inhibits moisture and vapour ingress while thermoforming provides a durable, cleanable, puncture resistant skin that helps reduce maintenance and operating costs; further benefits that influenced Pfizer’s decision to use it throughout its expanded clean room facilities at the US$2.25m plant.

The Grange Castle development is one of the largest integrated biopharmaceutical campuses in the world and is the only facility in Europe to manufacture biopharmaceuticals, pharmaceuticals and vaccines within the same facility.